Pharmaceutical Industry in Pediatric Drug Development: Partners and Collaborators With Academia and the FDA

被引：2
|
作者：
Mulberg, Andrew E. [1 ]
机构：
[1] Johnson&Johnson Pharmaceut Res & Dev, Mature Prod, Compound Dev Team, Titusville, NJ 08560 USA
来源：
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2008年 / 47卷 / 05期
关键词：
D O I：
10.1097/01.mpg.0000338970.57088.89
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：711 / 713
页数：3
相关论文
共 50 条
  • [41] Enhancing Drug Development and Drug Monitoring: Academia, Industry and Government Chart Common Goals
    Walter Wolf
    Dennis J. Atkinson
    Patrick M. Colletti
    Pharmaceutical Research, 2007, 24 : 2005 - 2007
  • [42] The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G.
    Albericio, Fernando
    MOLECULES, 2020, 25 (03):
  • [43] The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G.
    Albericio, Fernando
    MOLECULES, 2022, 27 (03):
  • [44] Translational Research and Drug Development in Psoriasis by Collaborative Efforts of Academia and Industry
    van de Kerkhof, Peter C. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (03) : 524 - 526
  • [45] The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G.
    Albericio, Fernando
    MOLECULES, 2021, 26 (03):
  • [46] Barriers to Alzheimer disease drug discovery and drug development in the pharmaceutical industry
    Anand, R
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 : S33 - S39
  • [47] The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G.
    Albericio, Fernando
    MOLECULES, 2019, 24 (04):
  • [48] How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement
    Severin, Thomas
    Corriol-Rohou, Solange
    Bucci-Rechtweg, Christina
    Haack, Kristina An
    Fuerst-Recktenwald, Sabine
    Lepola, Pirkko
    Norjavaara, Ensio
    Dehlinger-Kremer, Martine
    Haertter, Sebastian
    Cheung, S. Y. Amy
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (05) : 1076 - 1084
  • [49] How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement
    Thomas Severin
    Solange Corriol-Rohou
    Christina Bucci-Rechtweg
    Kristina an Haack
    Sabine Fuerst-Recktenwald
    Pirkko Lepola
    Ensio Norjavaara
    Martine Dehlinger-Kremer
    Sebastian Haertter
    S. Y. Amy Cheung
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 1076 - 1084
  • [50] Academia-Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
    Chabner, Bruce A.
    ONCOLOGIST, 2010, 15 (01): : 1 - 1
12345